Spots Global Cancer Trial Database for recurrent skin cancer
Every month we try and update this database with for recurrent skin cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Skin Cancer | NCT00747903 | Non-melanomatou... | aminolevulinic ... | 30 Years - | National Cancer Institute (NCI) | |
| Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer | NCT00017485 | Non-melanomatou... | HPPH | 18 Years - | Roswell Park Cancer Institute | |
| Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin Cancer | NCT00423397 | Non-melanomatou... | PEG-interferon ... gefitinib | 18 Years - | National Cancer Institute (NCI) | |
| Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer | NCT02324608 | Recurrent Skin ... Squamous Cell C... | cetuximab laboratory biom... | 18 Years - | Rutgers, The State University of New Jersey | |
| Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma | NCT02303041 | Carcinoma, Basa... Recurrent Skin ... Skin Neoplasms Basal Cell Nevu... | Buparlisib Sonidegib | 18 Years - | Stanford University | |
| Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer | NCT00663910 | Non-melanomatou... | Aminolevulinic ... biopsy diagnostic imag... therapeutic con... | 18 Years - 120 Years | The Cleveland Clinic | |
| Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC) | NCT01631331 | Basal Cell Carc... Recurrent Skin ... | vismodegib Mohs surgery | 18 Years - | Stanford University | |
| Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Skin Cancer | NCT00747903 | Non-melanomatou... | aminolevulinic ... | 30 Years - | National Cancer Institute (NCI) | |
| Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin | NCT01823679 | Squamous Cell C... Recurrent Skin ... | Capecitabine | 18 Years - | Stanford University | |
| Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma | NCT01791894 | Basal Cell Carc... Recurrent Skin ... | arsenic trioxid... | 18 Years - | Stanford University | |
| T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant | NCT00089180 | Actinic Keratos... Basal Cell Carc... Recurrent Skin ... Squamous Cell C... | liposomal T4N5 ... placebo laboratory biom... | 19 Years - | National Cancer Institute (NCI) | |
| Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer | NCT00002506 | Cervical Cancer Esophageal Canc... Head and Neck C... Lung Cancer Non-melanomatou... Penile Cancer | recombinant int... isotretinoin | 18 Years - | Hoag Memorial Hospital Presbyterian | |
| Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer | NCT00002506 | Cervical Cancer Esophageal Canc... Head and Neck C... Lung Cancer Non-melanomatou... Penile Cancer | recombinant int... isotretinoin | 18 Years - | Hoag Memorial Hospital Presbyterian | |
| Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin Cancer | NCT01292668 | Basal Cell Carc... Pain Recurrent Skin ... | methyl-5-aminol... photodynamic th... laser therapy | 18 Years - | Roswell Park Cancer Institute | |
| Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia | NCT00563290 | Recurrent Skin ... Squamous Cell C... Stage 0 Chronic... Stage I Chronic... | dasatinib laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck | NCT00006361 | Carcinoma of Un... Head and Neck C... Non-melanomatou... | semaxanib | 18 Years - | National Cancer Institute (NCI) | |
| Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia | NCT00563290 | Recurrent Skin ... Squamous Cell C... Stage 0 Chronic... Stage I Chronic... | dasatinib laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma | NCT02507076 | Basal Cell Carc... Eccrine Carcino... Recurrent Adult... Recurrent Melan... Recurrent Skin ... Squamous Cell C... Stage III Adult... Stage IIIB Mela... Stage IIIC Mela... Stage IV Adult ... Stage IV Melano... | isolated limb p... melphalan quality-of-life... | 18 Years - | Albert Einstein College of Medicine | |
| Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN) | NCT01465815 | Recurrent Skin ... Recurrent Squam... Squamous Cell C... Stage III Squam... Stage IVA Squam... Stage IVB Squam... | erlotinib hydro... linsitinib placebo radiation thera... therapeutic con... laboratory biom... | 18 Years - | OHSU Knight Cancer Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
